产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展

北京合志成化工产品有限公司

北京市
2
Years
张新伟
查看
基本信息
企业名称
北京合志成化工产品有限公司
企业地址
北京市北京市北京市朝阳区东三环南路25号16层1626室
成立日期
2023
企业规模(人)
10至19
年销售额(USD)
不愿意公开
企业简介
北京合志成化工产品有限公司是一家专业的API、精细化学品和医药中间体的供应商,在该行业拥有12年的经验。在山东、江苏设有合作研发中心,在江苏、山东、甘肃等设有多个生产基地。我们可以提供的服务和产品主要有: (1)药物分子砌块:主要为氟化物/溴化物/碘化物/硼化物的新材料结构,用于新药研发。(2)中间体以及API:为法规/非法规市场API制造商提供KSM和中间体,以及提供符合GMP条件下的API。产品范围涵盖仿制药和创新药。(3)CRO/CDMO业务:我们提供从克级、公斤级到吨级的合同生产服务。Beijing Toachem Chemical Co., Ltd. as a professional vendor of APIs, pharmaceutical intermediates and Fine chemicals, with 12 years of experience in the industry. It has cooperative R & D centers in Shandong and Jiangsu, and multiple production bases in Jiangsu, Shandong, Gansu, etc.The services and products we can offer mainly include: (1) Drug molecular building blocks: These are mainly new - material structures of fluorides/bromides/iodides/borides, which are used in new drug research and development. (2) Intermediates and APIs: We provide KSMs and intermediates for API manufacturers in both regulated and non - regulated markets, and also provide APIs from GMP manufacturer site. Our product range covers generic drugs and innovative drugs. (3) CRO/CDMO services: mainly provides outsourced production services from gram level, kilogram level to ton level to new drug research and development customers. 北京合志成化工製品有限公司は、API、精細化学品および医薬中間体の専門供給商で、当該業界で12年間の経験を持っています。山東省と江蘇省には共同研究開発センターを設置しており、江蘇省、山東省、甘粛省などに複数の生産拠点を持っています。当社が提供できるサービスと製品は主に以下の通りです。 (1)医薬分子ビルディングブロック:主にフッ化物、臭化物、ヨウ化物、ホウ化物の新素材構造で、新薬開発に使用されます。(2)中間体およびAPI:規制市場と非規制市場のAPIメーカーにKSMと中間体を提供し、GMP条件に適合したAPIも提供します。製品範囲は後発医薬品と革新的医薬品をカバーしています。 (3)CRO/CDMO事業:グラム単位、キログラム単位からトン単位までの委託生産サービスを提供します。
主要竞争优势
经验丰富的研发人员,发货速度,产品线丰富,接受小额订单,良好的信誉,优质服务
邮政编码
100021
官网地址
www.toachem.com
贸易信息
业务类型
制造商,分销商,贸易公司
主要销售市场
中国,西欧,东欧,亚洲
主营产品类别
中间体,合同外包、定制服务及咨询
合同定制与外包服务
CRO,CMO/CDMO
产品外销比重
75%
产品内销比重
25%
参展信息
主营产品
4-(Pyridin-2-ylcarbamoyl)phenyl)boronic acid;(2S)-2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-Pyrrolidinecarboxylic acid phenylmethyl ester;(1S,4R)-(4-Aminocyclopent-2-enyl)methanol hydrochloride;(2S,5R)-Methyl-5-[(benzyloxy)amino]piperidine-2-carboxylate ethanedioate;(2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide;1-Butanaminium, N,N,N-tributyl-, (1R,2S,5R)-2-(aminocarbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl sulfate;2-Cyanobenzyl bromide;6-Chloro-3-methyluracil;6-Chlorouracil;(R)-3-Piperidinamine dihydrochloride;9-[(2-Acetoxyethoxy)methyl]-N2-acetylguanine [DAAC];4-(chloro-difluoro-methoxy)-Phenylamine;2-(4-ethyl-3-iodophenyl)-2-methylpropanoic acid;4-chloro-3-nitrobenzonitrile;tert-butyl4-(4-ethyl-3-iodophenyl)-4-methyl-3-oxopentanoate;6-cyano-2-[1-[4-ethyl-3-[4-(4-morpholinyl)-1-piperidinyl]phenyl]-1-methylethyl]-1H-indole-3-carboxylic acid 1,1-dimethylethyl ester;1,3-Dimethylpiperidin-4-one;2-((4-Chlorophenyl)acetyl)benzoic acid;1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitrile;4-(1H-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine;(R)-Dihydro-4-propyl-2(3H)-furanone;3.4-Dihydro-7-hydroxy-2(1H)-quinolinone;7-Hydroxyquinolinone;4-Bromobenzothiophene;1-(Benzo[b]thiophen-4-yl)piperazine hydrochloride;(12aR)-3,4,12,12a-Tetrahydro-7-(phenylmethoxy)-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione;7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-ol 1985607-;(1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol;Methyl 2,4-dihydroxy-6-pentylbenzoate;5-pentyl 1,3-benzenediol [Olivetol];2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-D-cytidine [CAP5];1,2,3-Triacetyl-5-deoxy-D-ribose [CAP4];5-Fluorocytosine [5-FC];1-(2-chlorophenyl)-2-(2h-tetrazole-2-yl)ethyl-1-one;2-Bromo-2'-chloroacetophenone;Oxirane, (2-chlorophenyl)-, (2R)-;Trans-4-(Boc-aMino)cyclohexaneethanol;Tert-Butyl Trans-4-(2-oxoethyl)cyclohexylcarbamate;CarbaMic acid, N-[trans-4-[2-[(Methylsulfonyl)oxy]ethyl]cyclohexyl]-, 1,1-diMethylethyl ester;Cariprazine (N-1);3-(Trifluoromethyl)benzenepropanol;2-Chloroethyl carbamate;4-oxo-cyclohexanecarboxylicaciethyleste;(S)-1,2-propanediol;(2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl) phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate;(R)-3-Amino-1-Butanol [RABO];2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline;Lithium 4,6-dichloropyridazine-3-carboxylate hydrate;Ethyl 4,6-dihydroxypyridazine-3-carboxylate;(S)-(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine;Ethyl Isocyanatoacetate;Isocyanatocyclohexane;N,N,-Dicyclohexylurea;1,3-dicyclohexyl-barbituricaci;2-(Bromomethyl)-2-butylhexanoicacid;7-bromo-3,3-dibutyl-8-methoxy-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one;(R)-α-[N-(t-butoxycarbonylmethyl)carbamoyl]benzylamine;1,5-Benzothiazepin-8-ol, 3,3-dibutyl-2,3,4,5-tetrahydro-7-(methylthio)-5-phenyl-, 1,1-dioxide;4-Chloro-3-(Trifluoromethyl)Benzoic Acid;(4-cyclopentyl-3-(trifluoromethyl)phenyl)methanol;ethyl 2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetat;3'-Amino-2'-Hydroxybip henyl-3-Carboxylic Acid;3-Methyl-1-(3,4-dimethy lphenyl)-2-pyrazolin-5-one;Boc-D-Phenylglycinol;5-(2-Fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl) phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione;[(2Z)-2-[(3R,4R,5R)-3,5-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-4-[3-[[(1,1-dimethylethyl)diphenylsilyl]oxy]propoxy]-2-methylenecyclohexylidene]ethyl]diphenylphosphine oxide;(1R,3aR,4S,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-1,2,3,3a,4,5,6,7-octahydroinden-4-ol;Cholecalciferol(Vitamin D3);Tertiary Butyl [1R,2S, 5S]-2-Amino-5-Dimethylcarboyl) Cyclohexylcarbamate Oxalate;5-Methyl-6,7-Dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-Carboxylic Acid,Hydrochloride;2-[(5-Chloropyridin-2-yl)amino]-2-Oxoacetic Acid Ethyl ester Monohydrochloride;tert-butyl (1R,2S,5S)-2-aMino-5-(diMethylcarbaMoyl)cyclohexylcarbaMate;(S)-3-Cyclohexene-1-carboxylic Acid;(R)-5-Bromo-3-((1-methylpyrrolidin-2-yl)methyl)-1H-indole;D-Proline;1H-Pyrrole-3-carboxylic acid, 4-methyl-5-[2-(trifluoromethyl)phenyl]-,ethyl ester;4-Bromo-3-nitroanisole;2-[3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenol;(R)-5-HydroxyMethyl Tolterodine;methyl 5-(2,4-difluorophenyl)-4-methoxy-1H-pyrrole-3-carboxylate;5-(2,4-difluorophenyl)-4-methoxy-1H-pyrrole-3-carbaldehyde ;3-Fluorobenzenesulfony chloride;(Z)-2-cyanoethyl 2-(4-cyano-2-methoxybenzylidene)-3-oxobutanoate;5,6,7,8-tetrahydro-2,4-bis(trifluoroMethyl)-Pyrido[3,4-d]pyriMidine hydrochloride;(S)-3-(tert-butoxycarbonyl)-4-(5,5-difluoro-2-oxopiperidin-1-yl)butanoic acid;Cyclen;4,4-Dimethyl-3,5,8-trioxabic-yclo[5,1,0]Octane;3-Amino-3-Azabicyclo[3.3.0]octane Hydrochloride;2-Deoxy-2,2-difluoro-D-erythro-pentofuranose-3,5-dibenzoate-1-methanesulfonate [T-8];2-Deoxy-2,2-difluoro-D-erythro-pentafuranous-1-ulose-3,5-dibenzoate [T-6];2-(Methylamino)pyridine-3-methanol;(αS,βR)-β-(2,5-Difluorophenyl)-β-hydroxy-α-Methyl-1H-1,2,4-triazole-1-butanenitrile;(2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-Methyl-4-(1H-1,2,4-triazol-1-yl)thiobutyraMide;5-Bromo-2-fluorobenzaldehyde;Thianaphthene;Benzo[b]thiophene-2-Methanol, α-(5-broMo-2-fluorophenyl)-;Benzo[b]thiophene, 2-[(5-broMo-2-fluorophenyl)Methyl]-;3,4-Dimethoxycinnamic acid;(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl chloride;1,3-Diethyl-5-Nitro-6-AminoUracil;5,6-Diamino-1,3-diethyluracil Hydrochloride;(S)-2-Aminobutyramide Hydrochloride [SABAm];L(+)-2-Aminobutyric Acid [SABA ACID];(4aS,9bR)-6-bromo-1H,2H,3H,4H,4aH,5H,9bH-pyrido[4,3-b]indole;(4aS,9bR)-Ethyl 6-bromo-5-(2-(methylamino)-2-oxoethyl)-3,4,4a,5-tetrahydro-1H-pyrido[4,3-b]indole-2(9bH)-carboxylate;5-Pyrimidinol, 2,4-dimethyl- (9CI);2-Amino-5-fluoropyridine;(1S,5R)-1-(3-fluorophenyl)-3-oxabicyclo[3.1.0]hexan-2-one;((1S,2R)-1-(3-fluorophenyl)cyclopropane-1,2-diyl)dimethanol;(1R,2S)-2-(3-fluorophenyl)-2-(hydroxymethyl)cyclopropyl]-methyl acetate;(1R,2S)-2-[[(2,4-Dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)cyclopropanecarboxylic acid;benzofuran-6-arboxylic acid;(S) -2-Amino-3 -(3 -(Methylsulfonyl)Phenyl)Propanoic Acid;methyl 5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylate;(1R,5S)-3-ethyl-Bicyclo[3.2.0]hept-3-en-6-one;3-ethylbicyclo[3.2.0]hept-3-en-6-one;tert-Butyl O,O-dimethylphosphonoacetate;5-(4-Bromophenyl)-6-hydroxypyrimidin-4(1H)-one;5-(4-Bromophenyl)-4,6-dichloropyrimidine;N-[5-(4-broMophenyl)-6-chloro-4-pyriMidinyl]-N'-propyl-SulfaMide;SulfaMide, N-[5-(4-broMophenyl)-6-(2-hydroxyethoxy)-4-pyriMidinyl]-N'-propyl-;4-Fluoro-2-methoxy-5-nitroaniline;3-Chloropropionyl chloride;(S)-3-氨基丁腈盐酸盐;5-Bromoindole-2-carboxylic acid;1,3,2-Dioxathiolane, 4-Methyl-, 2,2-dioxide, (4R)-;5-BROMO-2-FLUORO-M-XYLENE;4-(2,4-Difluorobenzoyl)-piperidine hydrochloride;6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole Hydrochloride;3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]-pyrimidin-4-one;3-(2-Chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one;6-Bromo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin- 7(8H)-one;Tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate;4-(Trifluoromethoxy)Benzyl Bromide[TFOB];[(2S,3S)-2-(Benzyloxy)pentan-3-yl]hydrazine DTBA salt;(2S,3αS,7αS)-Octahydro-1H-indole-2-carboxylic acid;N-[(S)-1-Carbethoxy-1-butyl]-(S)-alanine;N-[(4-Fluorophenyl)methyl]-1-methyl-4-piperidinamine;1,2:4,5-di-o-isopropylidene-beta-d-erythro-2,3-hexodiulo-2,6-pyranose;2-((2,6-difluorobenzyl)(ethoxycarbonyl)amino)-4-((dimethylamino)methyl)-5-(4-nitrophenyl)thiophene-3-carboxylic acid;3-Amino-6-Methoxypyridazine;Ethyl 6,8-dichlorooctanoate;(R)-Lipoic acid;7,8-dihydro-5H-cyclohepta[b]pyridine-5,9(6H)-dione;1-(1-(1H-imidazole-1-carbonyl)piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one;dimethyl 5,9-dihydroxy-7H-cyclohepta[b]pyridine-6,8-dicarboxylate;(R)-3-cyclopentyl-3-(4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanenitrile;4-chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7h-pyrrolo[2,3-d]pyrimidine;3-cyclopentylacrylonitrile;6-Fluoro-1H-indole-4-carboxylic acid methyl ester;6-Bromo-4-Methoxypyrazolo[1,5-a]Pyridine-3-Carbonitrile;Ethyl 8-bromooctanoate;Main structure;Side Chain;SNAC;3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo [4,3-a]pyrazine Hydrochloride [TTTP];2,2-Dimethyl-1,3-Dioxane-4,6-Dione [Meldrum’s Acid];N-[(1R)-2-[1,1'-Biphenyl]-4-yl-1-(hydroxymethyl)ethyl]carbamic acid 1,1-dimethylethyl ester;(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid;Ethyl 2-(triphenylphosphoranylidene)propionate;4-(Ethylaminomethyl)pyridine;3,5-Difluorophenol;(R)-5,7-difluorochroman-4-ol;4-Cyanopyridinium-1-olate;Pyridine, 4-[5-(4-pyridinyl)-1H-1,2,4-triazol-3-yl]-, 1-oxide;7-Chloro-1,2,3,4-tetrahydro-1-(2-methyl-4-nitrobenzoyl)-5H-1-benzazepin-5-one;Carbamic acid,N-[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]-, ethyl este;(3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester;3-Amino-1-Adamantanol;L-Prolinamide;5-(2-Fluorophenyl)-1H-pyrrole-3-carbaldehyde;2,3,4,5-Tetrahydro-1,5-methano-1H-3-benzazepine hydrochloride;6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine,7,8,9,10-tetrahydro-8-(trifluoroacetyl);1,4-Dihydro-1,4-methanonaphthalene;Methyl 4-((1-Methylpiperidin-4-yl)Methoxy)-5-Methoxy-2-nitrobenzoate;Methyl 2-aMino-5-Methoxy-4-(1-Methylpiperidin-4-ylMethoxy)benzoate;5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile;MK-7 intermediate;methyl (2R)-2-amino-3-(7-methyl-1H-indazol-5-yl) propanoate dihydrochloride;1-(1-Methylpiperidin-4-yl)piperazinetrihydrochloride;3-(piperidin-4-yl)quinolin-2(1h)-one hydrochloride;(S)-4-Benzyl-2-oxazolidinone [SBOZ];(S)-4-Phenyl-2-oxazolidinone[SPOZ];8-Hydroxyquinoline [8-HQ];D-Mandelic Acid
参展展会
第二十三届世界制药原料中国展
展会时间
2025-03-06至2025-07-31
展位号
W7B09
展品分类
Active Pharmaceutical Ingredients;Intermediates & Fine Chemicals;CMO & CRO
参展信息
×